Emergent BioSolutions (EBS) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.29 +0.12%
EPS Growth %: -31.3%
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
PKE, LNN, More
EPS Growth %: -31.3%
Financial Fact:
Earnings per share - diluted: 0.45
Today's EPS Names:
PKE, LNN, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.18, $0.06 better than the analyst estimate of $0.12. Revenue for the quarter came in at $307.5 million versus the consensus estimate of $283.57 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman's Garrett sees investors dialing back tech exposure into H2
- Emergent BioSolutions wins $52.7M U.S. government smallpox vaccine deal
- Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
